Skip to Content

Rituximab

In the US, Rituximab (rituximab systemic) is a member of the following drug classes: antirheumatics, CD20 monoclonal antibodies and is used to treat Bullous Pemphigoid, Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Evan's Syndrome, Focal Segmental Glomerulosclerosis, Follicular Lymphoma, Granulomatosis with Polyangiitis, Idiopathic Thrombocytopenic Purpura, Mantle Cell Lymphoma, Microscopic polyangiitis, Non-Hodgkin's Lymphoma, Pemphigoid, Pemphigus, Pemphigus Vulgaris and Rheumatoid Arthritis.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XC02

CAS registry number (Chemical Abstracts Service)

0174722-31-7

Chemical Formula

C6416-H9874-N1688-O1987-S44

Molecular Weight

143860

Therapeutic Categories

Immunosuppressant

Antineoplastic agent

Microtubule inhibitor

Biological response modifier, BRM

Anti-CD20 monoclonal antibody

Chemical Name

Immunoglobulin G 1 (human-mouse monoclonal IDEC-C2B8 gama 1-chain anti-human antigen CD 20), disulfide wit human-mouse monoclonal IDEC-C2B8 kapa-chain, dimer (WHO)

Foreign Names

  • Rituximabum (Latin)
  • Rituximab (German)
  • Rituximab (French)
  • Rituximab (Spanish)

Generic Names

Brand Names

  • Acellbia
    Biocad, Georgia
  • Blitzima
    Celltrion, Estonia; Celltrion, Slovenia; Celltrion Healthcare, Sweden; Celltrion Healthcare Hungary, Poland
  • Mab Thera
    Roche Registration, Slovenia
  • MabThera
    F. Hoffmann-La Roche, Macedonia; F. Hoffmann-La Roche LTD, Serbia; Hoffmann-La Roche Ltd, Latvia; Productos Roche, Chile; Roche, Armenia; Roche, Argentina; Roche, Bosnia & Herzegowina; Roche, Belgium; Roche, Brazil; Roche, Colombia; Roche, Cyprus; Roche, Czech Republic; Roche, Denmark; Roche, Ecuador; Roche, Estonia; Roche, Egypt; Roche, Spain; Roche, Finland; Roche, France; Roche, Georgia; Roche, Greece; Roche, Hong Kong; Roche, Croatia (Hrvatska); Roche, Ireland; Roche, Italy; Roche, Lebanon; Roche, Lithuania; Roche, Moldova; Roche, Myanmar; Roche, Mexico; Roche, Norway; Roche, New Zealand; Roche, Oman; Roche, Peru; Roche, Philippines; Roche, Poland; Roche, Paraguay; Roche, Russian Federation; Roche, Sweden; Roche, Thailand; Roche, Tunisia; Roche, Turkey; Roche, Taiwan; Roche, Venezuela; Roche, Vietnam; Roche, South Africa; Roche D.O.O., Serbia; Roche Pharmaceutical, China; Roche Products, United Kingdom; Roche Registration, Romania; Roche Registration Limited, Iceland; Roche Uruguay, Uruguay
  • Mabthera
    Roche, Germany; Roche, Pakistan; Roche Products, Australia; Roche Registration, Netherlands
  • MabThera 100mg
    Haemato Pharm, Austria; Inopha, Austria; Orifarm, Austria; Roche, Hungary; Roche, Luxembourg; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland
  • MabThera 10mg/ml
    Roche, Israel
  • MabThera 1400mg
    Haemato Pharm, Austria; Orifarm, Austria; Roche, Israel; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland
  • Mabthera 1400mg/11.7ml
    Roche, Luxembourg
  • Mabthera 1600mg/13.4ml
    Roche, Luxembourg
  • MabThera 500mg
    Haemato Pharm, Austria; Inopha, Austria; Orifarm, Austria; Roche, Hungary; Roche, Luxembourg; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland
  • MabThera SC
    Roche, Brazil; Roche Products, Australia
  • Novex
    Elea, Argentina
  • Reditux
    Complex Therapeutics, Chile; Dr Reddy's Lab, Myanmar; Dr. Reddy's Laboratories, Vietnam
  • Rilast
    Hetero, Georgia
  • Ritemvia
    Celltrion, Estonia; Celltrion Healthcare, Latvia; Celltrion Healthcare, Netherlands; Orion Pharma, Denmark; Orion Pharma, Finland; Orion Pharma, Sweden
  • Ritemvia 500mg
    Celltrion Healthcare, Austria
  • Rituxan
    Genentech, United States; Hoffmann-La Roche, Canada; Zenyaku Kogyo, Japan
  • Rituxan Hycela [+ Hyaluronidase]
    Genentech, United States
  • Rituximab
    Baxter, New Zealand
  • Rituzena
    Celltrion Healthcare, Latvia; Celltrion Healthcare, Netherlands; Celltrion Healthcare, Sweden
  • Rixanthon
    Sandoz, Latvia
  • Rixathon
    Sandoz, Estonia; Sandoz, United Kingdom; Sandoz, Netherlands; Sandoz, Norway; Sandoz, Sweden; Sandoz, Slovenia; Sandoz GmbH, Greece
  • Rixathon 100mg
    Hexal, Germany
  • Rixathon 100mg/10ml
    Sandoz, Switzerland
  • Rixathon 500mg
    Hexal, Germany
  • Rixathon 500mg/50ml
    Sandoz, Switzerland
  • Riximyo
    Sandoz, Estonia; Sandoz, Latvia; Sandoz, Netherlands; Sandoz, Sweden; Sandoz, Slovenia; Sandoz GmbH, Greece
  • Truxima
    Biogaran, France; Celltrion, Georgia; Celltrion Healthcare, Lithuania; Celltrion Healthcare, Romania; Celltrion Healthcare Hungary Kft., Greece; Egis, Georgia; Kern Pharma, Spain; Mundipharma, Belgium; Mundipharma, Germany; Mundipharma Pharmaceuticals, Netherlands; Napp Pharmaceuticals, United Kingdom; Orion Pharma, Sweden
  • Truxima 100mg
    Mundipharma, Luxembourg
  • Truxima 100mg/10ml
    iQone, Switzerland
  • Truxima 500mg
    Mundipharma, Luxembourg
  • Truxima 500mg/50ml
    iQone, Switzerland
  • Tuxella
    Celltrion, Estonia
  • Zytux
    AryoGen, Georgia

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide